Relationship between DAPK promoter methylation and gefitinib resistance in lung cancer cell linesWU Weiqin, ZHANG Xiaoyuan, XU Haifeng, XU Jing, SHEN Jie, LU Kaihua481-485
Experimental study of tumstatin on growth of implanted liver cancer in nude miceZHU Yuerong, WANG Bing, HE Yujie, YANG Ruining, LOU Xiaowei, HAN Ping, QIU Hong486-489
The influences of sodium butyrate on endometrial cancer cell proliferation and the expression of NDRG1CHEN Ling, GENG Xiaoxing490-493
Predictive value of MITF gene amplification in metastatic melanoma patients receiving recombined human endostatin and dacarbazine as first-line treatment马家芳, 孔燕, 崔传亮, 梁龙, 张虔男, 唐碧霞, 代杰, 郭军494-497
Expression of TXNIP in breast cancer and its clinical significanceCHEN Wenjun, LI Rong, LUO Rongcheng498-501
Expression and clinical significance of P-cadherin in breast cancerLI Yuanyuan, ZHANG Lijie, WANG Zhuo502-505
The expression and prognostic value of Ki-67 in gastroenteropancreatic neuroendocrine tumorsZHOU Yue, QIU Jinrong, DING Xiaorong, YIN Yongmei506-510
Olanzapine combined granisetron and dexamethasone for the prevention of chemotherapy-induced emesis and nausea in cancer patients: A phase Ⅰ trialYUAN Lingyan, JIAO Xiaodong, WANG Zhan, QIAN Jianxn, LI Li, WANG Jiejun511-514
Clinical observation of non-small cell lung cancer with brain metastasis treated by gefitinibWANG Feng, WANG Lin, QIN Shukui, HUA Haiqing, CHEN Yingxia, LIU Xiufeng, YANG Ningrong515-520
Ovarian function castration combined with aromatase inhibitors in the treatment of metastatic breast cancer in premenopausal womenYANG Tingting, WANG Tao, BIAN Li, JIANG Hang, ZHANG Shaohua, WU Shikai, JIANG Zefei521-524
